Prev: Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?Next: High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease

Record 035 · Research · 2023
Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease
BMC Rheumatology · requested inclusion
“Phenome-wide association study of 70,043 individuals (Vanderbilt EHR), including 49,546 without an autoimmune disease, found ANA positivity associated with lupus and other autoimmune diagnoses, and in the no-autoimmune-disease sub-cohort with increased risk of Raynaud's syndrome and pneumopathies.”
Phenome-wide association study of 70,043 individuals (Vanderbilt EHR), including 49,546 without an autoimmune disease, found ANA positivity associated with lupus and other autoimmune diagnoses, and in the no-autoimmune-disease sub-cohort with increased risk of Raynaud's syndrome and pneumopathies. Candidate notes: Cohort: 70,043 individuals; 49,546 without autoimmune disease; 26,579 ANA+ (titer >=1:80) Without autoimmune disease: ANA+ associated with Raynaud's syndrome (OR 2.1) and alveolar/perialveolar pneumopathies (OR 1.4) ANA+ inversely associated with hepatitis C (OR 0.7), tobacco use disorder (OR 0.8), and depression (OR 0.8) Limits noted in the record: Retrospective EHR case-control design; ANA was tested for clinical indications, so the sample is not the general population Associations reported, not causal claims A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- healthy-people
- interpretation
- positive-ana
Research



